Onset of puberty and near adult height in short children born small for gestational age and treated with GH: Interim analysis of up to 10 years of treatment in Japan-Reference-Cited by-同舟云学术

Onset of puberty and near adult height in short children born small for gestational age and treated with GH: Interim analysis of up to 10 years of treatment in Japan

Published:2015 Issue:1 Volume:24 Page:15-25
ISSN:0918-5739
Container-title:Clinical Pediatric Endocrinology
language:en
Short-container-title:Clin Pediatr Endocrinol

Author:

Tanaka Toshiaki¹,Yokoya Susumu²,Seino Yoshiki³,Tada Hiroshi⁴,Mishina Jun⁵,Sato Takahiro⁶,Hiro Shintaro⁶,Ohki Nobuhiko⁶

Affiliation:

1. Tanaka Growth Clinic, Tokyo, Japan

2. National Center for Child Health and Development, Tokyo, Japan

3. JCHO Osaka Hospital, Osaka, Japan

4. Toho University School of Medicine, Tokyo, Japan

5. Sanchikai Medical Corporation, Kanagawa, Japan

6. Pfizer Japan Inc., Tokyo, Japan

Publisher

Japanese Society for Pediatric Endocrinology

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Pediatrics, Perinatology and Child Health

Link

https://www.jstage.jst.go.jp/article/cpe/24/1/24_9998/_pdf

Reference16 articles.

1. 1. The Japanese Society for Pediatric Endocrinology, Japan Society for Premature and Newborn MedicineGuideline for GH treatment in SGA short children. Nippon Shonika Gakkai Zasshi 2007;111: 641–6(in Japanese).

2. 2. Albertsson-Wikland, K, Karlberg, J. Natural growth in children born small for gestational age with and without catch-up growth. Acta Paediatr Suppl 1994;399: 64–70, discussion 71.

3. 3. Tanaka, T, Fujieda, K, Yokoya, S, Seino, Y, Tada, H, Mishina, J. Efficacy and safety of growth hormone treatment in children born small for gestational age in Japan. J Pediatr Endocrinol Metab 2008;21: 423–31.

4. 4. Tanaka, T, Yokoya, S, Fujieda, K, Seino, Y, Tada, H, Mishina, J, et al. Efficacy and safety of up to 8 years of long-term growth hormone treatment in short children born small for gestational age in Japan: analysis of the subpopulation according to the Japanese guideline. Clin Pediatr Endocrinol 2012;21: 57–68.

5. 5. Tanaka, T, Yokoya, S, Fujieda, K, Seino, Y, Tada, H, Mishina, J. Efficacy and safety of long-term growth hormone treatment up to 7 years in children born small for gestational age in Japan: analysis of subpopulation who meet with the criteria for GH treatment initiation of the Japanese guideline. Horumon To Rinsho 2010;58: 341–52(in Japanese).

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. International Consensus Guideline on Small for Gestational Age: Etiology and Management From Infancy to Early Adulthood;Endocrine Reviews;2023-01-13

2. Short stature due to intrauterine growth retardation. Clinical and hormonal-metabolic features, possibilities of growth-stimulating therapy;Problems of Endocrinology;2022-10-23

3. The long-term growth, cost-effectiveness, and glycemic effects of growth hormone therapy on children born small for gestational age over 10 years: a retrospective cohort study;Journal of Pediatric Endocrinology and Metabolism;2022-10-07

4. Factors influencing height gain in children born small for gestational age treated with recombinant growth hormone: what extent is puberty involved?;Therapeutic Advances in Endocrinology and Metabolism;2022-01

5. Seventy eight children born small for gestational age without catch-up growth treated with growth hormone from the prepubertal stage until adult height age. An evaluation of puberty and changes in the metabolic profile;Endocrinología, Diabetes y Nutrición;2021-11